Altai Protocol Library New Indication: Sacituzumab Govitecan Alone for Muscle-Invasive Bladder Cancer U. Darda Bayraktar, MD 2026-08-19
Altai Protocol Library New Reference: Trastuzumab Rezetecan for HER2+ Breast Cancer U. Darda Bayraktar, MD 2026-08-19
Altai Protocol Library New Reference: Zenocutumab for NRG1-Fusion Positive Cholangiocarcinoma U. Darda Bayraktar, MD 2026-08-13
Altai Protocol Library New Protocol: Neoadjuvant Toripalimab with Celecoxib for MSI-H Colorectal Cancer U. Darda Bayraktar, MD 2026-08-13
Altai Protocol Library New Protocol: Talquetamab with Daratumumab for Rel/Ref Multiple Myeloma U. Darda Bayraktar, MD 2026-08-13
Altai Protocol Library New Protocol: Revumenib, Decitabine, and Venetoclax for Rel/Ref AML U. Darda Bayraktar, MD 2026-08-13
Altai Protocol Library New Protocol: Polatuzumab with R-GemOx for Rel/Ref Large B-Cell Lymphoma U. Darda Bayraktar, MD 2026-08-13
Altai Protocol Library New Protocol: Pirtobrutinib with Venetoclax and Rituximab for CLL U. Darda Bayraktar, MD 2026-08-13
Altai Protocol Library New Protocol: Adjuvant Belzutifan with Pembrolizumab for Renal Cell Carcinoma U. Darda Bayraktar, MD 2026-08-13
Altai Protocol Library New Reference: Neoadjuvant Paclitaxel with Trastuzumab and Pertuzumab for HER2-Positive Breast Cancer U. Darda Bayraktar, MD 2026-08-13
